Business Context and Reporting Period
This Form 8-K Current Report was filed by MRI Interventions, Inc. (not Clearpoint Neuro, Inc.) on September 12, 2014. The filing discloses the execution of a new Employment Agreement with David W. Carlson, the Company's Chief Financial Officer, replacing a prior agreement dated June 21, 2012.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on executive compensation terms.
- Base Salary: $260,000 per annum.
- Retention Bonus: $250,000 total ($83,333 payable Dec 31, 2014; $166,667 payable July 31, 2015).
- Change of Control Bonus: $315,000 upon a sale transaction.
- Equity Vesting: Full vesting of outstanding stock options and restricted stock upon termination without cause/good reason or change of control.
Material Changes
The primary material change is the replacement of the CFO's prior employment contract with a new agreement containing specific retention incentives and enhanced severance provisions tied to a "Change of Control" (COC) event. The new agreement introduces a tiered COC Multiplier for severance calculations based on the value of a potential sale transaction.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary regarding business operations. Key contingencies and risks identified include:
- Severance Liability: Significant cash outflows are triggered if the CFO is terminated without cause or resigns for good reason, particularly within the window surrounding a change of control.
- Change of Control Multipliers: Severance payments in a sale transaction range from 0x to 1.5x base salary depending on the transaction value (e.g., 1.5x multiplier for sales over $110 million).
- Non-Compete: The CFO is restricted from competing with the Company for one year post-employment and from soliciting employees for two years.
Investor Verification Checklist
- Verify the total potential cash liability for the CFO's retention bonus and severance in the event of a sale transaction.
- Confirm the current status of the CFO's unvested stock options and restricted stock to assess the full value of the "Equity Award Terms."
- Review the definition of "Change of Control" and "Sale Transaction" in the full Employment Agreement (Exhibit 10.1) to understand the specific triggers for the COC Multiplier.
- Check for any subsequent filings regarding the actual payment of the retention bonus installments.